Tejnaksh Healthcare Share Price

Tejnaksh Healthcare Share Price

14.67
-0.73 (-4.74%)
BSE: 539428 | Healthcare | Small Cap | as on 05 Jun, 2026 • 03:29 PM IST

Tejnaksh Healthcare Annualised Returns

1 Year

-34.01%

3 Years

-24.79%

5 Years

-14.89%

10 Years

6.48%

Tejnaksh Healthcare Share Price Today


As of 6 Jun 2026, Tejnaksh Healthcare share price is ₹14.7. The stock opened at ₹15.4 and had closed at ₹15.4 the previous day. During today’s trading session, Tejnaksh Healthcare share price moved between ₹14.66 and ₹15.40, with an average price for the day of ₹15.03. Over the last 52 weeks, the stock has recorded a low of ₹10.65 and a high of ₹23.31. In terms of performance, Tejnaksh Healthcare share price has declined by 6.7% over the past six months and has declined by 34.01% over the last year.

Tejnaksh Healthcare Stock Performance

1W Return-4.37
1Y Return-33.01
Today's Low14.66
Prev. Close15.40
Mkt Cap (Cr.)29.80
1M Return-11.79
3Y Return-55.08
52-Week High23.31
Open15.40
PE Ratio21.57
6M Return-8.20
Today's High15.4
52-Week Low10.65
Face Value5

Tejnaksh Healthcare Share Price Chart

Tejnaksh Healthcare Company background

Founded in: 2008
Managing director: Ashish Vishwas Rawandale
Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a complete range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Companys achievements were the multiple records that motivates the customers to improve treatment for Urology.In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination. In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/ each by raising funds aggregating to Rs. 2.44 Crores. In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism.In 2016, Company set up the first indigenous PCNL simulation lab in the country and were made commercially available. Further, Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multispeciality center at Navi Mumbai in 2016.

Tejnaksh Healthcare Financial Highlights


For the full year FY2026–2027, revenue reached ₹11.18 crore and profit touched at ₹1.18 crore.
Read More
Tejnaksh Healthcare SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 2,09,815 in 5 years with a gain of -90,184 (-30.06%)

Tejnaksh Healthcare Fundamental

Market Cap (in crs)

29.80

Face Value

5

Turnover (in lacs)

1.64

Key Metrics

Qtr Change %
37.07% Fall from 52W High
16.6
Dividend yield 1yr %
0

Tejnaksh Healthcare Key Financials

View more
Loading chart...
Tejnaksh Healthcare Quarterly Revenue
Tejnaksh Healthcare Yearly Revenue
Tejnaksh Healthcare Quarterly Net Profit/Loss
Tejnaksh Healthcare Yearly Net Profit/Loss

Tejnaksh Healthcare Result Highlights

  • Tejnaksh Healthcare reported a 0.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 18.2%.
  • Its expenses for the quarter were down by 6.9% QoQ and 19.3% YoY.
  • The net profit increased 25.0% QoQ and decreased 18.6% YoY.
  • The earnings per share (EPS) of Tejnaksh Healthcare stood at 0.17 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Tejnaksh Healthcare Technical Analysis

Moving Averages Analysis
14.67
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5 EMA
15.00
10 EMA
15.00
12 EMA
15.00
20 EMA
15.00
26 EMA
15.00
50 EMA
14.90
100 EMA
15.00
200 EMA
16.20
Delivery & Volume
Loading chart...

Day

98.90%

Week

86.60%

Month

86.30%

Delivery & Volume

14.91
Pivot
Resistance
First Resistance
15.16
Second Resistance
15.65
Third Resistance
15.90
Support
First Support
14.42
Second support
14.17
Third Support
13.68
Relative Strength Index
46.44
Money Flow Index
38.33
MACD
0
MACD Signal
0.02
Average True Range
0.92
Average Directional Index
14.55
Rate of Change (21)
-8.26
Rate of Change (125)
-10.82
Compare

Tejnaksh Healthcare Shareholding Pattern

Promoter
73.8%
Public
26.2%

Tejnaksh Healthcare Latest News

30 MAY 2026
30 MAY 2026
30 MAY 2026

You can easily buy Tejnaksh Healthcare shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Tejnaksh Healthcare share price is ₹23.31 and ₹10.65 as of 5/6/2026.

Please be aware that Tejnaksh Healthcare stock prices are subject to continuous fluctuations due to various factors.